Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Rakesh Kumar

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Physiology

Anatomy

Phenomena

Phosphorylation

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
56
Vadlamudi, Ratna
27
Suresh, Rayala
27
Talukder, Amjad
25
Wang, Rui-An
25
Barnes, Christopher
24
Mandal, Mahitosh
22
Adam, Liana
20
Balasenthil, Seetharaman
18
Bagheri-Yarmand, Rozita
15
Gururaj, Anupama
15
Yang, Zhibo
14
Manavathi, Bramanandam
14
Fidler, Isaiah
12
Li, Feng
12
Mishra, Sandip

Sign-in to see all Coauthors

Publications

TOP 3
O'Malley Bert W; Kumar Rakesh
Nuclear receptor coregulators in cancer biology.
Li Da-Qiang; Ohshiro Kazufumi; Reddy Sirigiri Divijendra Natha; Pakala Suresh B; Lee Mong-Hong; Zhang Yanping; Rayala Suresh K; Kumar Rakesh
E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
Reddy Sirigiri Divijendra Natha; Pakala Suresh B; Ohshiro Kazufumi; Rayala Suresh K; Kumar Rakesh
MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rakesh Kumar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: O'Malley Bert W; Kumar Rakesh
Nuclear receptor coregulators in cancer biology.
Cancer research 2009;69(21):8217-22.
2009: Li Da-Qiang; Ohshiro Kazufumi; Reddy Sirigiri Divijendra Natha; Pakala Suresh B; Lee Mong-Hong; Zhang Yanping; Rayala Suresh K; Kumar Rakesh
E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(41):17493-8.
2009: Reddy Sirigiri Divijendra Natha; Pakala Suresh B; Ohshiro Kazufumi; Rayala Suresh K; Kumar Rakesh
MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.
Cancer research 2009;69(14):5639-42.
2009: Molli P R; Li D Q; Murray B W; Rayala S K; Kumar R
PAK signaling in oncogenesis.
Oncogene 2009;28(28):2545-55.
2009: Kumar Anupam; Molli Poonam R; Pakala Suresh B; Bui Nguyen Tri M; Rayala Suresh K; Kumar Rakesh
PAK thread from amoeba to mammals.
Journal of cellular biochemistry 2009;107(4):579-85.
2008: Reddy Sirigiri Divijendra Natha; Ohshiro Kazufumi; Rayala Suresh K; Kumar Rakesh
MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.
Cancer research 2008;68(20):8195-200.
2008: Molli Poonam R; Adam Liana; Kumar Rakesh
Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6161-70.
2008: Talukder A H; Li D-Q; Manavathi B; Kumar R
Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.
Oncogene 2008;27(39):5233-42.
2008: Molli P R; Singh R R; Lee S W; Kumar R
MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene.
Oncogene 2008;27(14):1971-80.
2008: Song Chunying; Wen Wenyu; Rayala Suresh K; Chen Mingzhi; Ma Jianpeng; Zhang Mingjie; Kumar Rakesh
Serine 88 phosphorylation of the 8-kDa dynein light chain 1 is a molecular switch for its dimerization status and functions.
The Journal of biological chemistry 2008;283(7):4004-13.
2008: Ohshiro Kazufumi; Rayala Suresh K; El-Naggar Adel K; Kumar Rakesh
Delivery of cytoplasmic proteins to autophagosomes.
Autophagy 2008;4(1):104-6.
2007: Rayala Suresh K; Martin Emil; Sharina Iraida G; Molli Poonam R; Wang Xiaoping; Jacobson Raymond; Murad Ferid; Kumar Rakesh
Dynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19470-5.
2007: Aoki Hiroshi; Yokoyama Tomohisa; Fujiwara Keishi; Tari Ana M; Sawaya Raymond; Suki Dima; Hess Kenneth R; Aldape Kenneth D; Kondo Seiji; Kumar Rakesh; Kondo Yasuko
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6603-9.
2007: Fontenot Danielle Renee; den Hollander Petra; Vela Eric Michael; Newman Robert; Sastry Jagannadha K; Kumar Rakesh
Dynein light chain 1 peptide inhibits human immunodeficiency virus infection in eukaryotic cells.
Biochemical and biophysical research communications 2007;363(4):901-7.
2007: Ohshiro Kazufumi; Rayala Suresh K; Kondo Seiji; Gaur Amitabh; Vadlamudi Ratna K; El-Naggar Adel K; Kumar Rakesh
Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
Cancer research 2007;67(17):8164-71.
2007: Singh Rajesh R; Kumar Rakesh
MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.
Journal of mammary gland biology and neoplasia 2007;12(2-3):115-25.
2007: Balasenthil Seetharaman; Gururaj Anupama E; Talukder Amjad H; Bagheri-Yarmand Rozita; Arrington Ty; Haas Brian J; Braisted John C; Kim Insun; Lee Norman H; Kumar Rakesh
Identification of Pax5 as a target of MTA1 in B-cell lymphomas.
Cancer research 2007;67(15):7132-8.
2007: Bagheri-Yarmand Rozita; Balasenthil Seetharaman; Gururaj Anupama E; Talukder Amjad H; Wang Yui-Hsi; Lee Ju Han; Kim Young Sik; Zhang Xinaglan; Jones Daniel M; Medeiros L Jeffrey; Stephens L Clifton; Liu Yong-Jun; Lee Norman; Kim Insun; Kumar Rakesh
Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.
Cancer research 2007;67(15):7062-7.
2007: Manavathi Bramanandam; Peng Shaohua; Rayala Suresh K; Talukder Amjad H; Wang Minhua H; Wang Rui-An; Balasenthil Seetharaman; Agarwal Neeraj; Frishman Laura J; Kumar Rakesh
Repression of Six3 by a corepressor regulates rhodopsin expression.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(32):13128-33.
2007: Rayala Suresh K; Kumar Rakesh
Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(7):408-11.
2007: Gururaj Anupama E; Peng Shaohua; Vadlamudi Ratna K; Kumar Rakesh
Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).
Molecular endocrinology (Baltimore, Md.) 2007;21(8):1847-60.
2007: Barnes Christopher J; Ohshiro Kazufumi; Rayala Suresh K; El-Naggar Adel K; Kumar Rakesh
Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4291-9.
2007: Manavathi Bramanandam; Rayala Suresh K; Kumar Rakesh
Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1.
The Journal of biological chemistry 2007;282(27):19820-30.
2007: Acconcia Filippo; Barnes Christopher J; Singh Rajesh R; Talukder Amjad H; Kumar Rakesh
Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(16):6782-7.
2007: Meng Qingchang; Rayala Suresh K; Gururaj Anupama E; Talukder Amjad H; O'Malley Bert W; Kumar Rakesh
Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(14):5866-71.
2007: Nair Sujit S; Guo Zhiyong; Mueller Judith M; Koochekpour Shahriar; Qiu Yun; Tekmal Rajeshwar Rao; Schüle Roland; Kung Hsing-Jien; Kumar Rakesh; Vadlamudi Ratna K
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Molecular endocrinology (Baltimore, Md.) 2007;21(3):613-24.
2007: Manavathi Bramanandam; Kumar Rakesh
Metastasis tumor antigens, an emerging family of multifaceted master coregulators.
The Journal of biological chemistry 2007;282(3):1529-33.
2007: Manavathi Bramanandam; Singh Kamini; Kumar Rakesh
MTA family of coregulators in nuclear receptor biology and pathology.
Nuclear receptor signaling 2007;5():e010.
2006: Acconcia Filippo; Manavathi Bramanandam; Mascarenhas Joseph; Talukder Amjad H; Mills Gordon; Kumar Rakesh
An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
Cancer research 2006;66(22):11030-8.
2006: den Hollander Petra; Rayala Suresh K; Coverley Dawn; Kumar Rakesh
Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
Cancer research 2006;66(22):11021-9.
2006: Verma Amit; Wang Huamin; Manavathi Bramanandam; Fok Jansina Y; Mann Aman P; Kumar Rakesh; Mehta Kapil
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.
Cancer research 2006;66(21):10525-33.
2006: Zhang Hao; Singh Rajesh R; Talukder Amjad H; Kumar Rakesh
Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway.
Genes & development 2006;20(21):2943-8.
2006: Ohshiro Kazufumi; Rayala Suresh K; Williams Michelle D; Kumar Rakesh; El-Naggar Adel K
Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):5994-9.
2006: Manavathi Bramanandam; Acconcia Filippo; Rayala Suresh K; Kumar Rakesh
An inherent role of microtubule network in the action of nuclear receptor.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(43):15981-6.
2006: Mann Aman P; Verma Amit; Sethi Gautam; Manavathi Bramanandam; Wang Huamin; Fok Jansina Y; Kunnumakkara Ajaikumar B; Kumar Rakesh; Aggarwal Bharat B; Mehta Kapil
Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.
Cancer research 2006;66(17):8788-95.
2006: Singh Rajesh R; Kaluarachchi Kumaralal; Chen Mingzhi; Rayala Suresh K; Balasenthil Seetharaman; Ma Jianpeng; Kumar Rakesh
Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s.
The Journal of biological chemistry 2006;281(35):25612-21.
2006: Gururaj Anupama E; Holm Caroline; Landberg Göran; Kumar Rakesh
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer.
Cell cycle (Georgetown, Tex.) 2006;5(13):1407-10.
2006: Rayala Suresh K; den Hollander Petra; Manavathi Bramanandam; Talukder Amjad H; Song Chunying; Peng Shaohua; Barnekow Angelika; Kremerskothen Joachim; Kumar Rakesh
Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells.
The Journal of biological chemistry 2006;281(28):19092-9.
2006: Acconcia Filippo; Kumar Rakesh
Signaling regulation of genomic and nongenomic functions of estrogen receptors.
Cancer letters 2006;238(1):1-14.
2006: Rayala Suresh K; Molli Poonam R; Kumar Rakesh
Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.
Cancer research 2006;66(12):5985-8.
2006: den Hollander Petra; Kumar Rakesh
Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells.
Cancer research 2006;66(11):5941-9.
2006: Balasenthil Seetharaman; Broaddus Russell R; Kumar Rakesh
Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas.
Human pathology 2006;37(6):656-61.
2006: Kumar Rakesh; Gururaj Anupama E; Barnes Christopher J
p21-activated kinases in cancer.
Nature reviews. Cancer 2006;6(6):459-71.
2006: Singh Rajesh R; Gururaj Anupama E; Vadlamudi Ratna K; Kumar Rakesh
9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.
The Journal of biological chemistry 2006;281(22):15394-404.
2006: Bagheri-Yarmand Rozita; Mazumdar Abhijit; Sahin Aysegul A; Kumar Rakesh
LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.
International journal of cancer. Journal international du cancer 2006;118(11):2703-10.
2006: Manavathi Bramanandam; Kumar Rakesh
Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
Journal of cellular physiology 2006;207(3):594-604.
2006: Kumar Rakesh
A look back to move forward: scientists in reflections.
Cancer biology & therapy 2006;5(5):554-6.
2006: Wang R-A; Zhang H; Balasenthil S; Medina D; Kumar R
PAK1 hyperactivation is sufficient for mammary gland tumor formation.
Oncogene 2006;25(20):2931-6.
2006: Gururaj Anupama E; Singh Rajesh R; Rayala Suresh K; Holm Caroline; den Hollander Petra; Zhang Hao; Balasenthil Seetharaman; Talukder Amjad H; Landberg Goran; Kumar Rakesh
MTA1, a transcriptional activator of breast cancer amplified sequence 3.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6670-5.
2006: Zhang Hao; Stephens L Clifton; Kumar Rakesh
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1479-86.
2006: Acconcia Filippo; Barnes Christopher J; Kumar Rakesh
Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells.
Endocrinology 2006;147(3):1203-12.
2006: Talukder A H; Meng Q; Kumar R
CRIPak, a novel endogenous Pak1 inhibitor.
Oncogene 2006;25(9):1311-9.
2006: Rayala Suresh K; Mascarenhas Joseph; Vadlamudi Ratna K; Kumar Rakesh
Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis.
Molecular cancer therapeutics 2006;5(2):230-7.
2006: Gururaj Anupama E; Rayala Suresh K; Vadlamudi Ratna K; Kumar Rakesh
Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):1001s-1007s.
2006: Rayala Suresh K; Talukder Amjad H; Balasenthil Seetharaman; Tharakan Robbin; Barnes Christopher J; Wang Rui-An; Aldaz C Marcelo; Khan Sohaib; Kumar Rakesh
P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
Cancer research 2006;66(3):1694-701.
2006: Rayala Suresh K; Hollander Petra den; Balasenthil Seetharaman; Molli Poonam R; Bean Andrew J; Vadlamudi Ratna K; Wang Rui-An; Kumar Rakesh
Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.
The Journal of biological chemistry 2006;281(7):4395-403.
2005: Kumar Rakesh
Commentary: targeting colorectal cancer through molecular biology.
Seminars in oncology 2005;32(6 Suppl 9):S37-9.
2005: Singh Rajesh R; Barnes Christopher J; Talukder Amjad H; Fuqua Suzanne A W; Kumar Rakesh
Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Cancer research 2005;65(22):10594-601.
2005: Singh Rajesh R; Kumar Rakesh
Steroid hormone receptor signaling in tumorigenesis.
Journal of cellular biochemistry 2005;96(3):490-505.
2005: Wang Rui-An; Zhao Ming; Meistrich Marvin L; Kumar Rakesh
Stage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testes: implications in spermiogenesis.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2005;53(10):1235-43.
2005: Vadlamudi Ratna K; Manavathi Bramanandam; Balasenthil Seetharaman; Nair Sujit S; Yang Zhibo; Sahin Aysegul A; Kumar Rakesh
Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
Cancer research 2005;65(17):7724-32.
2005: Manavathi Bramanandam; Nair Sujit S; Wang Rui-An; Kumar Rakesh; Vadlamudi Ratna K
Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Cancer research 2005;65(13):5571-7.
2005: Vadlamudi Ratna K; Balasenthil Seetharaman; Sahin Aysegul A; Kies Merrill; Weber Randal S; Kumar Rakesh; El-Naggar Adel K
Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.
Human pathology 2005;36(6):670-5.
2005: Rayala Suresh K; den Hollander Petra; Balasenthil Seetharaman; Yang Zhibo; Broaddus Russell R; Kumar Rakesh
Functional regulation of oestrogen receptor pathway by the dynein light chain 1.
EMBO reports 2005;6(6):538-44.
2005: Vadlamudi Ratna K; Manavathi Bramanandam; Singh Rajesh R; Nguyen Diep; Li Feng; Kumar Rakesh
An essential role of Pak1 phosphorylation of SHARP in Notch signaling.
Oncogene 2005;24(28):4591-6.
2005: Vadlamudi Ratna K; Barnes Christopher J; Rayala Suresh; Li Feng; Balasenthil Seetharaman; Marcus Stevan; Goodson Holly V; Sahin Aysegul A; Kumar Rakesh
p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.
Molecular and cellular biology 2005;25(9):3726-36.
2005: Singh Rajesh R; Song Chunying; Yang Zhibo; Kumar Rakesh
Nuclear localization and chromatin targets of p21-activated kinase 1.
The Journal of biological chemistry 2005;280(18):18130-7.
2005: Barnes Christopher J; Li Feng; Talukder Amjad H; Kumar Rakesh
Growth factor regulation of a 26S proteasomal subunit in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2868-74.
2005: Kumar Rakesh; Gururaj Anupama E; Vadlamudi Ratna K; Rayala Suresh K
The clinical relevance of steroid hormone receptor corepressors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2822-31.
2005: Yang Zhibo; Rayala Suresh; Nguyen Diep; Vadlamudi Ratna K; Chen Shiuan; Kumar Rakesh
Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions.
Cancer research 2005;65(8):3179-84.
2005: Kumar Rakesh; Hung Mien-Chie
Signaling intricacies take center stage in cancer cells.
Cancer research 2005;65(7):2511-5.
2005: Yang Zhibo; Vadlamudi Ratna K; Kumar Rakesh
Dynein light chain 1 phosphorylation controls macropinocytosis.
The Journal of biological chemistry 2005;280(1):654-9.
2005: Gururaj Anupama; Kumar Rakesh
Polypeptide growth factors and their receptors.
Cancer treatment and research 2005;126():1-14.
2005: Gururaj Anupama E; Rayala Suresh K; Kumar Rakesh
p21-activated kinase signaling in breast cancer.
Breast cancer research : BCR 2005;7(1):5-12.
2004: Vadlamudi Ratna K; Balasenthil Seetharaman; Broaddus Russell R; Gustafsson Jan-Ake; Kumar Rakesh
Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
The Journal of clinical endocrinology and metabolism 2004;89(12):6130-8.
2004: Kumar Rakesh; Wang Rui-An; Barnes Christopher J
Coregulators and chromatin remodeling in transcriptional control.
Molecular carcinogenesis 2004;41(4):221-30.
2004: Gururaj Anupama; Barnes Christopher J; Vadlamudi Ratna K; Kumar Rakesh
Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.
Oncogene 2004;23(49):8118-27.
2004: Nair Sujit S; Mishra Sandip K; Yang Zhibo; Balasenthil Seetharaman; Kumar Rakesh; Vadlamudi Ratna K
Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
Cancer research 2004;64(18):6416-23.
2004: Talukder Amjad H; Gururaj Anupama; Mishra Sandip K; Vadlamudi Ratna K; Kumar Rakesh
Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
Molecular and cellular biology 2004;24(15):6581-91.
2004: Bagheri-Yarmand Rozita; Talukder Amjad H; Wang Rui-An; Vadlamudi Ratna K; Kumar Rakesh
Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
Development (Cambridge, England) 2004;131(14):3469-79.
2004: Mishra Sandip K; Talukder Amjad H; Gururaj Anupama E; Yang Zhibo; Singh Rajesh R; Mahoney My G; Francí Clara; Vadlamudi Ratna K; Kumar Rakesh
Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.
The Journal of biological chemistry 2004;279(31):32709-15.
2004: Vadlamudi Ratna K; Bagheri-Yarmand Rozita; Yang Zhibo; Balasenthil Seetharaman; Nguyen Diep; Sahin Aysegul A; den Hollander Petra; Kumar Rakesh
Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.
Cancer cell 2004;5(6):575-85.
2004: Balasenthil Seetharaman; Barnes Christopher J; Rayala Suresh K; Kumar Rakesh
Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
FEBS letters 2004;567(2-3):243-7.
2004: Yang Zhibo; Barnes Christopher J; Kumar Rakesh
Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3621-8.
2004: Mishra Sandip K; Yang Zhibo; Mazumdar Abhijit; Talukder Amjad H; Larose Louise; Kumar Rakesh
Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase.
Oncogene 2004;23(25):4422-9.
2004: Vadlamudi Ratna K; Li Feng; Barnes Christopher J; Bagheri-Yarmand Rozita; Kumar Rakesh
p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.
EMBO reports 2004;5(2):154-60.
2004: Yang Zhibo; Bagheri-Yarmand Rozita; Wang Rui-An; Adam Liana; Papadimitrakopoulou Vali Vassiliki; Clayman Gary L; El-Naggar Adel; Lotan Reuben; Barnes Christopher J; Hong Waun Ki; Kumar Rakesh
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):658-67.
2004: Balasenthil Seetharaman; Sahin Aysegul A; Barnes Christopher J; Wang Rui-An; Pestell Richard G; Vadlamudi Ratna K; Kumar Rakesh
p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
The Journal of biological chemistry 2004;279(2):1422-8.
2004: Vadlamudi Ratna K; Kumar Rakesh
p21-activated kinase 1: an emerging therapeutic target.
Cancer treatment and research 2004;119():77-88.
2004: Barnes Christopher J; Kumar Rakesh
Biology of the epidermal growth factor receptor family.
Cancer treatment and research 2004;119():1-13.
2003: Vadlamudi Ratna K; Kumar Rakesh
P21-activated kinases in human cancer.
Cancer metastasis reviews 2003;22(4):385-93.
2003: Barnes Christopher J; Kumar Rakesh
Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets.
Cancer metastasis reviews 2003;22(4):301-7.
2003: Kumar Rakesh; Wang Rui-An; Bagheri-Yarmand Rozita
Emerging roles of MTA family members in human cancers.
Seminars in oncology 2003;30(5 Suppl 16):30-7.
2003: Yang Zhibo; Bagheri-Yarmand Rozita; Balasenthil Seetharaman; Hortobagyi Gabriel; Sahin Aysegul A; Barnes Christopher J; Kumar Rakesh
HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):3198-203.
2003: Barnes Christopher J; Vadlamudi Ratna K; Mishra Sandip K; Jacobson Raymond H; Li Feng; Kumar Rakesh
Functional inactivation of a transcriptional corepressor by a signaling kinase.
Nature structural biology 2003;10(8):622-8.
2003: Vadlamudi Ratna K; Sahin Aysegul A; Adam Liana; Wang Rui An; Kumar Rakesh
Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215.
FEBS letters 2003;543(1-3):76-80.
2003: Wang Rui-An; Vadlamudi Ratna K; Bagheri-Yarmand Rozita; Beuvink Iwan; Hynes Nancy E; Kumar Rakesh
Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands.
The Journal of cell biology 2003;161(3):583-92.
2003: Cheema Sangeeta K; Mishra Sandip K; Rangnekar Vivek M; Tari Ana M; Kumar Rakesh; Lopez-Berestein Gabriel
Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
The Journal of biological chemistry 2003;278(22):19995-20005.
2003: Mishra Sandip K; Mazumdar Abhijit; Vadlamudi Ratna K; Li Feng; Wang Rui-An; Yu Wei; Jordan V Craig; Santen Richard J; Kumar Rakesh
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
The Journal of biological chemistry 2003;278(21):19209-19.
2003: Bagheri-Yarmand Rozita; Vadlamudi Ratna K; Kumar Rakesh
Activating transcription factor 4 overexpression inhibits proliferation and differentiation of mammary epithelium resulting in impaired lactation and accelerated involution.
The Journal of biological chemistry 2003;278(19):17421-9.
2003: Kumar Rakesh
Another tie that binds the MTA family to breast cancer.
Cell 2003;113(2):142-3.
2003: Barnes Christopher J; Bagheri-Yarmand Rozita; Mandal Mahitosh; Yang Zhibo; Clayman Gary L; Hong Waun Ki; Kumar Rakesh
Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Molecular cancer therapeutics 2003;2(4):345-51.
2003: Talukder Amjad H; Mishra Sandip K; Mandal Mahitosh; Balasenthil Seetharaman; Mehta Sonal; Sahin Aysegul A; Barnes Christopher J; Kumar Rakesh
MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.
The Journal of biological chemistry 2003;278(13):11676-85.
2003: Mazumdar Abhijit; Kumar Rakesh
Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
FEBS letters 2003;535(1-3):6-10.
2002: Kumar Rakesh; Vadlamudi Ratna K
Emerging functions of p21-activated kinases in human cancer cells.
Journal of cellular physiology 2002;193(2):133-44.
2002: Wang Rui-An; Mazumdar Abhijit; Vadlamudi Ratna K; Kumar Rakesh
P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium.
The EMBO journal 2002;21(20):5437-47.
2002: Talukder Amjad H; Bagheri-Yarmand Rozita; Williams Ruth R E; Ragoussis Jiannis; Kumar Rakesh; Raz Avraham
Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3285-9.
2002: Kumar Rakesh; Wang Rui-An
Protein kinases in mammary gland development and cancer.
Microscopy research and technique 2002;59(1):49-57.
2002: Vadlamudi Ratna K; Li Feng; Adam Liana; Nguyen Diep; Ohta Yasutaka; Stossel Thomas P; Kumar Rakesh
Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1.
Nature cell biology 2002;4(9):681-90.
2002: Kumar Rakesh; Wang Rui-An; Mazumdar Abhijit; Talukder Amjad H; Mandal Mahitosh; Yang Zhibo; Bagheri-Yarmand Rozita; Sahin Aysegul; Hortobagyi Gabriel; Adam Liana; Barnes Christopher J; Vadlamudi Ratna K
A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.
Nature 2002;418(6898):654-7.
2002: Li Feng; Adam Liana; Vadlamudi Ratna K; Zhou Hongyi; Sen Subrata; Chernoff Jonathan; Mandal Mahitosh; Kumar Rakesh
p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells.
EMBO reports 2002;3(8):767-73.
2002: Mandal Mahitosh; Li Feng; Kumar Rakesh
Heregulin up-regulates heat shock protein-70 expression in breast cancer cells.
Anticancer research 2002;22(4):1965-9.
2002: Li Feng; Mandal Mahitosh; Mishra Sandip K; Barnes Christopher J; Kumar Rakesh
Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3.
FEBS letters 2002;524(1-3):49-53.
2002: Talukder Amjad H; Wang Rui-An; Kumar Rakesh
Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.
Oncogene 2002;21(27):4289-300.
2002: Barnes Christopher J; Li Feng; Mandal Mahitosh; Yang Zhibo; Sahin Aysegul A; Kumar Rakesh
Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Cancer research 2002;62(5):1251-5.
2002: Vadlamudi Ratna K; Adam Liana; Nguyen Diep; Santos Manes; Kumar Rakesh
Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2.
Journal of cellular physiology 2002;190(2):189-99.
2001: Li F; Mandal M; Barnes C J; Vadlamudi R K; Kumar R
Growth factor regulation of the molecular chaperone calnexin.
Biochemical and biophysical research communications 2001;289(3):725-32.
2001: Kumar R; Yarmand-Bagheri R
The role of HER2 in angiogenesis.
Seminars in oncology 2001;28(5 Suppl 16):27-32.
2001: Mishra S K; Mandal M; Mazumdar A; Kumar R
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
FEBS letters 2001;507(1):88-94.
2001: Vadlamudi R K; Wang R A; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
The Journal of biological chemistry 2001;276(41):38272-9.
2001: Bagheri-Yarmand R; Mandal M; Taludker A H; Wang R A; Vadlamudi R K; Kung H J; Kumar R
Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.
The Journal of biological chemistry 2001;276(31):29403-9.
2001: Adam L; Vadlamudi R K; McCrea P; Kumar R
Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
The Journal of biological chemistry 2001;276(30):28443-50.
2001: Mandal M; Vadlamudi R; Nguyen D; Wang R A; Costa L; Bagheri-Yarmand R; Mendelsohn J; Kumar R
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.
The Journal of biological chemistry 2001;276(13):9699-704.
2001: Talukder A H; Jorgensen H F; Mandal M; Mishra S K; Vadlamudi R K; Clark B F; Mendelsohn J; Kumar R
Regulation of elongation factor-1alpha expression by growth factors and anti-receptor blocking antibodies.
The Journal of biological chemistry 2001;276(8):5636-42.
2001: Mandal M; Olson D J; Sharma T; Vadlamudi R K; Kumar R
Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells.
Gastroenterology 2001;120(1):71-8.
2001: Adam L; Mazumdar A; Sharma T; Jones T R; Kumar R
A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2.
Cancer research 2001;61(1):81-7.
2001: Mazumdar A; Adam L; Boyd D; Kumar R
Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
Cancer research 2001;61(1):400-5.
2001: Mazumdar A; Wang R A; Mishra S K; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi R K; Kumar R
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Nature cell biology 2001;3(1):30-7.
2000: Kumar R; Mandal M; Vadlamudi R
New insights into anti-HER-2 receptor monoclonal antibody research.
Seminars in oncology 2000;27(6 Suppl 11):84-91; discussion 92-100.
2000: Vadlamudi R K; Wang R A; Talukder A H; Adam L; Johnson R; Kumar R
Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.
Molecular and cellular biology 2000;20(23):9092-101.
2000: Bagheri-Yarmand R; Vadlamudi R K; Wang R A; Mendelsohn J; Kumar R
Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis.
The Journal of biological chemistry 2000;275(50):39451-7.
2000: Vadlamudi R K; Adam L; Wang R A; Mandal M; Nguyen D; Sahin A; Chernoff J; Hung M C; Kumar R
Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells.
The Journal of biological chemistry 2000;275(46):36238-44.
2000: Le X F; Vadlamudi R; McWatters A; Bae D S; Mills G B; Kumar R; Bast R C
Differential signaling by an anti-p185(HER2) antibody and heregulin.
Cancer research 2000;60(13):3522-31.
2000: Kumar R; Xie K; Eue I; Dong Z; Killion J J; Fidler I J
Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002.
International journal of immunopharmacology 2000;22(6):431-43.
2000: Fidler I J; Singh R K; Yoneda J; Kumar R; Xu L; Dong Z; Bielenberg D R; McCarty M; Ellis L M
Critical determinants of neoplastic angiogenesis.
Cancer journal (Sudbury, Mass.) 2000;6 Suppl 3():S225-36.
2000: Adam L; Vadlamudi R; Mandal M; Chernoff J; Kumar R
Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1.
The Journal of biological chemistry 2000;275(16):12041-50.
2000: Adam L; Bandyopadhyay D; Kumar R
Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2.
Biochemical and biophysical research communications 2000;267(3):692-6.
2000: Talukder A H; Adam L; Raz A; Kumar R
Heregulin regulation of autocrine motility factor expression in human tumor cells.
Cancer research 2000;60(2):474-80.
2000: Talukder A H; Vadlamudi R; Mandal M; Kumar R
Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4.
Cancer research 2000;60(2):276-81.
1999: Vadlamudi R; Adam L; Talukder A; Mendelsohn J; Kumar R
Serine phosphorylation of paxillin by heregulin-beta1: role of p38 mitogen activated protein kinase.
Oncogene 1999;18(51):7253-64.
1999: Cuevas B; Lu Y; Watt S; Kumar R; Zhang J; Siminovitch K A; Mills G B
SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
The Journal of biological chemistry 1999;274(39):27583-9.
1999: Mandal M; Adam L; Kumar R
Redistribution of activated caspase-3 to the nucleus during butyric acid-induced apoptosis.
Biochemical and biophysical research communications 1999;260(3):775-80.
1999: Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
Cancer research 1999;59(12):2843-6.
1999: Vadlamudi R; Mandal M; Adam L; Steinbach G; Mendelsohn J; Kumar R
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
Oncogene 1999;18(2):305-14.
1999: Kumar R; Yoneda J; Fidler I J; Dong Z
GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice.
Journal of leukocyte biology 1999;65(1):102-8.
1998: Adam L; Vadlamudi R; Kondapaka S B; Chernoff J; Mendelsohn J; Kumar R
Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.
The Journal of biological chemistry 1998;273(43):28238-46.
1998: Eue I; Kumar R; Dong Z; Killion J J; Fidler I J
Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(5):340-51.
1998: Shinohara H; Killion J J; Kuniyasu H; Kumar R; Fidler I J
Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2053-63.
1998: Mandal M; Adam L; Mendelsohn J; Kumar R
Nuclear targeting of Bax during apoptosis in human colorectal cancer cells.
Oncogene 1998;17(8):999-1007.
1998: Dong Z; Yoneda J; Kumar R; Fidler I J
Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.
The Journal of experimental medicine 1998;188(4):755-63.
1998: Dong Z; Killion J J; Kumar R; Eue I; Yang X; Lu W; Su B; Fidler I J
Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002.
Journal of leukocyte biology 1998;63(6):766-74.
1998: Dong Z; Juang S H; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler I J
Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
Cancer immunology, immunotherapy : CII 1998;46(3):137-46.
1998: Fidler I J; Kumar R; Bielenberg D R; Ellis L M
Molecular determinants of angiogenesis in cancer metastasis.
The cancer journal from Scientific American 1998;4 Suppl 1():S58-66.
1998: Kumar R; Yoneda J; Bucana C D; Fidler I J
Regulation of distinct steps of angiogenesis by different angiogenic molecules.
International journal of oncology 1998;12(4):749-57.
1998: Kumar R; Fidler I J
Angiogenic molecules and cancer metastasis.
In vivo (Athens, Greece) 1998;12(1):27-34.
1998: Mandal M; Bandyopadhyay D; Goepfert T M; Kumar R
Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
Oncogene 1998;16(2):217-25.
1998: Bandyopadhyay D; Mandal M; Adam L; Mendelsohn J; Kumar R
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells.
The Journal of biological chemistry 1998;273(3):1568-73.
1997: Kumar R; Eue I; Dong Z; Killion J J; Fidler I J
Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002.
Cancer biotherapy & radiopharmaceuticals 1997;12(5):333-40.
1997: Mandal M; Kumar R
Bcl-2 modulates telomerase activity.
The Journal of biological chemistry 1997;272(22):14183-7.
1997: Dong Z; Kumar R; Yang X; Fidler I J
Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma.
Cell 1997;88(6):801-10.
1996: Kumar R; Dong Z; Fidler I J
Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(11):5104-11.
1992: Chaljub G; Van Fleet R; Guinto F C; Crow W N; Martinez L; Kumar R
MR imaging of clival and paraclival lesions.
AJR. American journal of roentgenology 1992;159(5):1069-74.
1992: Varma D G; Ayala A G; Carrasco C H; Guo S Q; Kumar R; Edeiken J
Chondrosarcoma: MR imaging with pathologic correlation.
Radiographics : a review publication of the Radiological Society of North America, Inc 1992;12(4):687-704.
1992: Varma D G; Moulopoulos A; Sara A S; Leeds N; Kumar R; Kim E E; Wallace S
MR imaging of extracranial nerve sheath tumors.
Journal of computer assisted tomography 1992;16(3):448-53.
1991: Varma D G; Kumar R; Carrasco C H; Guo S Q; Richli W R
MR imaging of periosteal chondroma.
Journal of computer assisted tomography 1991;15(6):1008-10.
1991: Goodman P; Kumar R; Alperin J B
Diffuse intraabdominal lymphoma complicating idiopathic myelofibrosis: CT demonstration.
AJR. American journal of roentgenology 1991;156(6):1189-90.
1991: Chaljub G; Guinto F C; Crow W N; Kumar R
MRI diagnosis of spinal cord compression in beta-thalassemia.
Spine 1991;16(5):583-4.
1991: Kumar R; Matasar K; Stansberry S; Shirkhoda A; David R; Madewell J E; Swischuck L E
The calcaneus: normal and abnormal.
Radiographics : a review publication of the Radiological Society of North America, Inc 1991;11(3):415-40.
1990: Kumar R; Moser R P; Madewell J E; Edeiken J
Parosteal osteogenic sarcoma arising in cranial bones: clinical and radiologic features in eight patients.
AJR. American journal of roentgenology 1990;155(1):113-7.
1990: Kumar R; Madewell J E; Lindell M M; Swischuk L E
Fibrous lesions of bones.
Radiographics : a review publication of the Radiological Society of North America, Inc 1990;10(2):237-56.
1989: David R; Oria R A; Kumar R; Singleton E B; Lindell M M; Shirkhoda A; Madewell J E
Radiologic features of eosinophilic granuloma of bone.
AJR. American journal of roentgenology 1989;153(5):1021-6.
1989: David R; Lamki N; Fan S; Singleton E B; Eftekhari F; Shirkhoda A; Kumar R; Madewell J E
The many faces of neuroblastoma.
Radiographics : a review publication of the Radiological Society of North America, Inc 1989;9(5):859-82.
1989: Kumar R; Madewell J E; Swischuk L E; Lindell M M; David R
The clavicle: normal and abnormal.
Radiographics : a review publication of the Radiological Society of North America, Inc 1989;9(4):677-706.
1989: Kumar R; Balachandran S; Shirkhoda A; Morettin L B
Pancreatic carcinoma masquerading as renal cell carcinoma.
Urologic radiology 1989;11(1):20-4.
1988: Kumar R; Guinto F C; Madewell J E; David R; Shirkhoda A
Expansile bone lesions of the vertebra.
Radiographics : a review publication of the Radiological Society of North America, Inc 1988;8(4):749-69.
1988: Kumar R; Guinto F C; Madewell J E; Swischuk L E; David R
The vertebral body: radiographic configurations in various congenital and acquired disorders.
Radiographics : a review publication of the Radiological Society of North America, Inc 1988;8(3):455-85.
1988: Bedi D G; Kumar R; Morettin L B; Gourley K
Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
European journal of radiology 1988;8(2):109-12.
1988: Winsett M Z; Amparo E G; Fawcett H D; Kumar R; Johnson R F; Bedi D G; Winsett O E
Renal transplant dysfunction: MR evaluation.
AJR. American journal of roentgenology 1988;150(2):319-23.
1988: Winsett M Z; Kumar R; Balachandran S; Bedi D G; Gallagher P; Fagan C J
Pseudocyst following splenectomy: impact of CT and ultrasound on its diagnosis and management.
Gastrointestinal radiology 1988;13(2):177-9.
1987: Kumar R; Madewell J E
Rheumatoid and seronegative arthropathies of the foot.
Radiologic clinics of North America 1987;25(6):1263-88.
1987: Kumar R; Madewell J E; Swischuk L E
The normal and abnormal growth plate.
Radiologic clinics of North America 1987;25(6):1133-53.
1987: Kumar R; David R; Madewell J E; Lindell M M
Radiographic spectrum of osteogenic sarcoma.
AJR. American journal of roentgenology 1987;148(4):767-72.

Sign-in to see more